论文部分内容阅读
本院应用 TAD 治疗急慢性病毒性肝炎,取得较好疗效,现将结果报告如下。1 对象与方法1.1 观察对象本组200例,分治疗及对照两组。(1)治疗组98例,男性76例,年龄20岁～56岁,平均年龄38.4岁。急性无黄疸型肝炎(TIH)24例,慢性肝炎(CH)68例(轻度18例,中度28例,重度22例),肝炎肝硬变(LC)6例。(2)对照组102例,男性79例,年龄21岁～58岁,平均年龄37.8岁。AIH23例,CH74例(轻度24例,中度29例,重度21例),LC5例。两组病人在年龄、性别和病情轻重等方面无显著差异(P>0.05)。
TAD hospital treatment of acute and chronic viral hepatitis, and achieved good results, the results are reported as follows. 1 objects and methods 1.1 observed objects The group of 200 cases, divided into treatment and control groups. (1) The treatment group 98 cases, 76 males, aged 20 to 56 years, mean age 38.4 years old. There were 24 cases of acute jaundice hepatitis (TIH), 68 cases of chronic hepatitis (CH), 18 cases of mild, 28 cases of moderate and 22 cases of severe hepatitis and 6 cases of liver cirrhosis (LC). (2) The control group of 102 cases, 79 males, aged 21 years to 58 years, with an average age of 37.8 years. 23 cases of AIH, 74 cases of CH (mild 24 cases, moderate 29 cases, severe 21 cases), LC5 cases. There was no significant difference between the two groups in terms of age, sex and severity (P> 0.05).